FDA issues immediate recall of Grand Chateaux Sangria Forte over safety, legality concerns

According to the FDA, the product has been widely advertised on social media and available on the Ghanaian market, despite not being registered with the authority.

In a statement on March 18, 2025, the FDA explained that the recall was prompted by violations of Sections 97, 98, and 103 of the Public Health Act, 2012 (Act 851), which mandates that all food and beverage products must be registered before distribution.

Failure to comply means the sale and distribution of the product is illegal.

Also, the FDA said the packaging and size of the products were misleading and could pose a risk of accidental alcohol ingestion by children posing a danger to health and safety.

“Retailers and wholesalers must immediately cease distribution and sale of these products. All stocks should be returned to the nearest outlets of Cave and Garden Ghana Limited or the FDA’s offices nationwide. The importer has been sanctioned, and regulatory measures are being enforced to ensure compliance,” parts of the statement read.

The FDA then reaffirmed its commitment to public health and safety, urging the public to report any instances of the sale of these products via its communication channels.